Associations Between Serum 25‐Hydroxyvitamin D Concentrations and Multiple Health Conditions, Physical Performance Measures, Disability, and All‐Cause Mortality: The Concord Health and Ageing in Men Project
- 27 February 2014
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 62 (3) , 417-425
Abstract
Objectives: To explore associations between serum 25‐hydroxyvitamin D ( 25( OH )D) levels and a wide range of health conditions, physical performance measures, disability, and mortality in a large epidemiological study to identify an optimum range for 25( OH )D concentrations. Design: Cross‐sectional study, with additional prospective data on falls and mortality. Setting: Concord Health and Ageing in Men Project, S ydney, A ustralia. Participants: Community‐dwelling men aged 70 and older (N = 1,659). Measurements: Serum 25( OH )D levels, general health status, self‐reported diseases, physical performance measures, disability (activities of daily living and instrumental activities of daily living) and falls. Results: Fair, poor, and very poor health; self‐reported diabetes mellitus; hyperglycemia; depression; muscle weakness; poor balance; and all‐cause mortality were all associated with serum 25( OH )D levels less than 50 nmol/L, even after adjustment for confounding. The findings also suggest that, in older men, for a wide range of health conditions, physical performance measures, disability, falls, and mortality, the optimum range of 25( OH )D is between 50.0 and 74.9 nmol/L, with no additional benefit for 25( OH )D levels of 75.0 nmol/L or greater. Conclusion: Programs aimed at achieving an optimum range of serum 25( OH )D at levels between 50.0 and 74.9 nmol/L may have overall health benefits and such levels are adequate for older men.Keywords
Funding Information
- National Health and Medical Research Council
- Ageing and Alzheimer's Research Fund
- ARC Centre of Excellence in Population Ageing Research
This publication has 39 references indexed in Scilit:
- Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older AdultsAnnals of Internal Medicine, 2012
- Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population‐based studyClinical Endocrinology, 2011
- Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml)Best Practice & Research Clinical Endocrinology & Metabolism, 2011
- Serum 25-Hydroxyvitamin D, Calcium Intake, and Risk of Type 2 Diabetes After 5 YearsDiabetes Care, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2011
- Vitamin D nutritional policy needs a vision for the futureExperimental Biology and Medicine, 2010
- Diagnosis and management of vitamin D deficiencyBMJ, 2010
- Global vitamin D status and determinants of hypovitaminosis DOsteoporosis International, 2009
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Estimates of optimal vitamin D statusOsteoporosis International, 2005